Aerie COO Mitro Provides Staffing, Pipeline Update

In this interview, Tom Mitro, COO of Aerie Pharmaceuticals, says the new hires brought on to prepare for commercial sale of Rhopressa bring new life and energy into a company hitting its stride. He also provides an update on the firm’s glaucoma pipeline.